NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium San Francisco, CA – January 25, 2020: NantHealth, Inc....
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...
Innovative new treatments and advanced therapies have provided a fundamental shift in oncology care. This evolution has transformed outcomes for...
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Cancer care is costly and complex; and if you don’t have the tools needed to effectively manage your cancer spend,...
This designation reaffirms that NantHealth is a trusted leader in utilization review and is committed to quality and transformative healthcare,...
NantHealth to Showcase Advancements in Technology that Enable Value-Based Care and Discuss Technology’s Role in Reducing Healthcare Costs Culver City,...
Culver City, CA – June 13, 2019 – NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its...
Culver City, California and San Diego – June 19, 2018 – NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present at...